Otrivin (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Otrivin, is an alpha‑adrenergic nasal decongestant presented as a nasal spray for topical intranasal use. It relieves nasal congestion associated with common colds, sinusitis and allergic rhinitis in adults and children. GNH USA supplies Otrivin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Otrivin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Otrivin (xylometazoline) acts on the nasal mucosa to reduce swelling and improve airflow.

- Common cold: alleviates nasal congestion and promotes easier breathing. - Acute sinusitis: reduces mucosal edema, helping drainage and symptom relief. - Allergic rhinitis: decreases nasal passage swelling caused by allergens. - Nasal congestion in children: provides short‑term relief of blockage in pediatric patients.

Side effects are generally mild and related to local irritation of the nasal mucosa.

Common Side Effects: - Burning or stinging sensation in the nose. - Nasal dryness or crusting. - Sneezing shortly after application. - Mild headache. - Transient epistaxis (nosebleed).

Serious or Rare Side Effects: - Persistent nasal irritation or ulceration. - Severe or prolonged nosebleeds. - Allergic reactions such as rash, itching, or swelling of the face. - Rebound congestion with prolonged use (>5‑7 days). - Hypertension exacerbation in susceptible individuals.

When using Otrivin, follow these safety considerations:

- Age restriction: not recommended for children under 2 years without medical advice. - Duration limit: limit use to 3‑5 days to avoid rebound congestion. - Pre‑existing conditions: use cautiously in patients with hypertension, heart disease, diabetes, or thyroid disorders. - Pregnancy and lactation: consult a healthcare professional before use. - Drug interactions: avoid concurrent use with other nasal decongestants. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Xylometazoline may interact with other medications that affect vascular tone or blood pressure.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may potentiate hypertensive effects. - Systemic sympathomimetics (e.g., pseudoephedrine): increased risk of hypertension.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: possible reduction in blood‑pressure‑lowering efficacy. - Beta‑blockers: may blunt the vasoconstrictive response. - Other topical nasal decongestants: risk of additive irritation and rebound congestion. - Herbal supplements containing ephedra: potential synergistic vasoconstriction.